New study explores Mepolizumab's impact on nasal polyps and asthma
NCT ID NCT06069310
First seen Apr 19, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This observational study follows 40 patients with chronic sinusitis and nasal polyps, with or without severe asthma, who are taking mepolizumab. Researchers will collect nasal, blood, and sputum samples over 12 months to track changes in symptoms, airway bacteria, and gene activity. The goal is to better understand who responds best to treatment and how it affects the need for steroids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pulmonary Dept First ICU Evangelismos Hospital
Athens, 10676, Greece
-
Pulmonary Dept First ICU, Evagelismos Hospital
Athens, Attica, 10676, Greece
Conditions
Explore the condition pages connected to this study.